Skip to main content
. 2022 Sep 9;101(36):e30466. doi: 10.1097/MD.0000000000030466

Table 2.

Adverse events during the procedure.

Group 1 (n = 40) Group 2 (n = 40) P value
Patient movements affecting the procedure 18 (45.0%) 2 (5.0%) <0.001
Hypotension (mean arterial pressure < 60 mm Hg) 0 (0%) 0 (0%) 1.000
Patients requiring ephedrine (systolic blood pressure < 80 mm Hg) 0 (0%) 0 (0%) 1.000
Apnea with desaturation (SpO2 < 90%) 0 (0%) 9 (22.5%) 0.002
Postoperative nausea and vomiting 0 (0%) 0 (0%) 1.000
REMI-induced hyperalgesia 0 (0%) 0 (0%) 1.000

Data are shown as number (percentage). Group 1: initial REMI Ce of 1.0 ng/mL; Group 2: initial REMI Ce of 2.0 ng/mL.

Ce = effect-site concentration; REMI = remifentanil, SpO2 = peripheral oxygen saturation.